Saudi Arabia Introduces Digital Process For Travellers Carrying Controlled Drugs
Doha, Qatar: Saudi Arabia has introduced a new set of guidelines that enables travellers to obtain online clearance permits for prescribed medications.
The system is designed to support patients and enhance travel efficiency, while maintaining safety standards, the Saudi Food and Drug Authority (SFDA) stated as it released procedures to obtain clearance permit.
Read Also-
Saudi Arabia strongly condemns remarks by Israeli Prime Minister
Gulf tourists say Polish mountain town is a cool place
With poetry and chants, Omanis strive to preserve ancient language
Kuwait begins rolling out tourist visas on arrival for GCC residents
The SFDA confirms that all information related to controlled drug permits is available through its Controlled Drugs System (CDS) at [ ]. These drugs include narcotic and psychotropic substances that are strictly regulated under the country's law.
Travelelrs can now easily apply for a permit through the CDS platform by creating a personal account, submitting an electronic clearance permit request with the patient's details and trip information, and uploading supporting documents such as a prescription, medical report, and proof of identity.
They can also add multiple medications by providing accurate details, including the trade name, active ingredient, drug concentration, and quantity or pack size.
Applicants must include documents that prove the medical need for the medication, whether it is for the traveller or another patient.
Travellers can also track the status of the application, which is clearly classified as 'Submitted', 'Completed', 'Rejected', or 'Incomplete'.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment